Long-term treatment with streptozocin/5-fluorouracil chemotherapy in patients with metastatic pancreatic neuroendocrine tumors: Case series

RATIONALE: Pancreatic neuroendocrine tumors (pNETs) are rare entities representing 1% to 3% of all malignant pancreatic neoplasms. Current guidelines recommend a combination of streptozocin (STZ) and 5-fluorouracil (5-FU) for patients with metastatic well-differentiated pNETs requiring systemic ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Christian, Kreissl, Michael C., Klose, Silke, Krause, Andreas, Keitel, Verena, Venerito, Marino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797514/
https://www.ncbi.nlm.nih.gov/pubmed/35089197
http://dx.doi.org/10.1097/MD.0000000000028610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797514/
https://www.ncbi.nlm.nih.gov/pubmed/35089197
http://dx.doi.org/10.1097/MD.0000000000028610

Ejemplares similares